# Chronic Kidney Disease Registry Platform Study

> **NCT06117852** · — · ACTIVE_NOT_RECRUITING · sponsor: **AstraZeneca** · enrollment: 5000 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06117852
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-28
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06117852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06117852, "Chronic Kidney Disease Registry Platform Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06117852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*